Shinichiro Koizumi

Shinichiro Koizumi

Auto-generated profile, based on publicly available information

Shinichiro Koizumi

Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
TOTomoya Oishi
Tomoya Oishi
SKShinichiro Koizumi
Shinichiro Koizumi
KKKazuhiko Kurozumi
Kazuhiko Kurozumi
Glioma is the most common primary brain tumor, and its prognosis is poor. Glioma cells are highly invasive to the brain parenchyma. It is difficult to achieve complete resection due to the nature of the brain tissue, and tumors that invade the parenchyma often recur. The invasiveness of tumor cells has been studied from various aspects, and the related molecular mechanisms are gradually becoming clear. Cell adhesion factors and extracellular matrix factors have a strong influence on glioma invasion. The molecular mechanisms that enhance the invasiveness of glioma stem cells, which have been investigated in recent years, have also been clarified. In addition, it has been discussed from both basic and clinical perspectives that current therapies can alter the invasiveness of tumors, and there is a need to develop therapeutic approaches to glioma invasion in the future. In this review, we will summarize the factors that influence the invasiveness of glioma based on the environment of tumor cells and tissues, and describe the impact of the treatment of glioma on invasion in terms of molecular biology, and the novel therapies for invasion that are currently being developed.

23 April 2024 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
TOTomoya Oishi
Tomoya Oishi
SKShinichiro Koizumi
Shinichiro Koizumi
KKKazuhiko Kurozumi
Kazuhiko Kurozumi

13 December 2021 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
SKShinichiro Koizumi
Shinichiro Koizumi
YSYuki Shiraishi
Yuki Shiraishi
IMIppei Makita
Ippei Makita
MKMakoto Kadowaki
Makoto Kadowaki
TSTetsuro Sameshima
Tetsuro Sameshima
KKKazuhiko Kurozumi
Kazuhiko Kurozumi
BACKGROUND: Robotic technology is increasingly used in neurosurgery. The authors reported a new technique for fence-post tube placement using robot-guided frameless stereotaxic technology with neuronavigation in patients with glioma. OBSERVATIONS: Surgery was performed using the StealthStation S8 linked to the Stealth Autoguide cranial robotic guidance platform and a high-resolution three-dimensional (3D) surgical microscope. A surgical plan was created to determine the removal area using fence-post tube placement at the tumor and normal brain tissue boundary. Using this surgical plan, the robotic system allowed quick and accurate fence-post tube positioning, automatic alignment of the needle insertion and measurement positions in the brain, and quick and accurate puncture needle insertion into the brain tumor. Use of a ventricular drainage tube for the outer needle cylinder allowed placement of the puncture needle in a single operation. Furthermore, use of a high-resolution 3D exoscope allowed the surgeon to simultaneously view the surgical field image and the navigation screen with minimal line-of-sight movement, which improved operative safety. The position memory function of the 3D exoscope allowed easy switching between the exoscope and the microscope and optimal field of view adjustment. LESSONS: Fence-post tube placement using robot-guided frameless stereotaxic technology, neuronavigation, and an exoscope allows precise glioma resection.

8 September 2022 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
MHMakoto Horikawa
Makoto Horikawa
SKShinichiro Koizumi
Shinichiro Koizumi
TOTomoya Oishi
Tomoya Oishi
TYTaisuke Yamamoto
Taisuke Yamamoto
MIMasashi Ikeno
Masashi Ikeno
KKKazuhiko Kurozumi
Kazuhiko Kurozumi

3 March 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
SKShinichiro Koizumi
Shinichiro Koizumi
MIMoriya Iwaizumi
Moriya Iwaizumi
SBSatoshi Baba
Satoshi Baba
MUMineko Ushiama
Mineko Ushiama
MHMakoto Hirata
Makoto Hirata
KKKazuhiko Kurozumi
Kazuhiko Kurozumi
BACKGROUND: Advances in cancer genome analysis technology have made individual cancer genome profiling (CGP) possible. CGP can indicate the presence of hereditary tumors, which are caused by germline pathogenic variants in oncogenes or tumor suppressor genes; if a hereditary tumor is suspected, multigene panel testing (MGPT) is performed. Genomic medicine thus plays an important role in diagnosing hereditary tumors. OBSERVATIONS: A 41-year-old man presented with headache and depressive symptoms. Close examination revealed a mass lesion with cystic components in the right parietal lobe. The tumor was removed via craniotomy and was pathologically diagnosed as a high-grade glioma. CGP of the tumor area revealed a high tumor mutation burden and multiple presumed germline pathogenic variants. MGPT of peripheral blood detected a germline pathogenic variant in MSH6 . The patient was therefore diagnosed with Lynch syndrome. LESSONS: Family history and genetic risk assessments, including CGP, are important for diagnosing genetic diseases. Next-generation sequencing technology is essential for genetic analyses, and if many genetic mutations are identified using tumor-only CGP, MGPT of peripheral blood is an efficient option. In addition, MSH6 variant analysis is important for diagnosing Lynch syndrome and determining treatment. In particular, functional analysis of somatic variants is essential for understanding disease associations. https://thejns.org/doi/10.3171/CASE24718

14 August 2026 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
SKSatoru Kida
Satoru Kida
TOTomoya Oishi
Tomoya Oishi
TYTomohiro Yamasaki
Tomohiro Yamasaki
YKYoshinobu Kamio
Yoshinobu Kamio
TSTomoya Sakamoto
Tomoya Sakamoto
KKKazuhiko Kurozumi
Kazuhiko Kurozumi